In one paragraphArticle in Cancer survivorship research & care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Lindsey J MattickDivision of Supportive Care in Cancer, Department of Surgery, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0002-2119-9309 Po-Ju LinDivision of Supportive Care in Cancer, Department of Surgery, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0003-0362-1120 Francisco Cartujano-BarreraDepartment of Environmental Medicine and Public Health Sciences, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0001-8069-1750 Deborah J OssipDepartment of Environmental Medicine and Public Health Sciences, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA.
Umang GadaDivision of Supportive Care in Cancer, Department of Surgery, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA.
Allison M MagnusonDivision of Hematology and Oncology, Department of Medicine, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0002-0968-8265 Luke J PepponeDivision of Supportive Care in Cancer, Department of Surgery, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0002-0346-5191 Jeremy McGuireDivision of Supportive Care in Cancer, Department of Surgery, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0002-3439-8227 Judith O HopkinsSoutheast Clinical Oncology Research Consortium, NCI Community Oncology Research Program (SCOR NCORP), Winston-Salem, NC, USA.ORCID 0000-0002-9829-1242 Janos MolnarHawaii, NCI Community Oncology Research Program (NCORP), Honolulu, HI, USA.
J Scott MaulAurora, NCI Community Oncology Research Program (NCORP), Two Rivers, WI, USA.
Karen M MustianDivision of Supportive Care in Cancer, Department of Surgery, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0001-6525-7518 Funding
URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7MSoutheast Clinical Oncology Research Consortium, Inc. (SCOR)UG1CA189858 · NCI · SOUTHEAST CLINICAL ONCOL RES CONSORTIUM · PI Judith O Hopkins, William J Irvin · 2014 to 2026
$38.8MNCI Community Oncology Research Program (NCORP) - Community SitesUG1CA190140 · NCI · AURORA HEALTH CARE, INC. · PI Sigrun Hallmeyer, THOMAS J SAPHNER · 2014 to 2026
$20.0MThe Hawaii NCORPUG1CA189804 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI Jared Acoba, Jeffrey Lee Berenberg · 2014 to 2026
$15.7MUniversity of Rochester Wilmot Cancer Institute Support GrantP30CA272302 · NCI · UNIVERSITY OF ROCHESTER · PI JONATHAN W FRIEDBERG · 2025 to 2026
$6.4MYoga Versus CBT-I for Insomnia in Cancer Survivors and Biobehavioral MechanismsR01CA181064 · NCI · UNIVERSITY OF ROCHESTER · PI MUSTIAN, KAREN M. · 2014 to 2019
$3.1MClinical and Translational Cancer Control Research Training ProgramT32CA102618 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, Gary R Morrow · 2019 to 2026
$2.7MNCI NIH HHS P30 CA272302NCI NIH HHS R01 CA181064NCI NIH HHS T32 CA102618NCI NIH HHS UG1 CA189804NCI NIH HHS UG1 CA189858NCI NIH HHS UG1 CA189961NCI NIH HHS UG1 CA190140
6 · The paper itselfAbstract
Purpose: To evaluate the associations of obesity and cancer-related fatigue (CRF) among breast cancer survivors, and the impact of their co-occurrence on physical function. Methods: In a nationwide randomized clinical trial, we assessed body mass index (BMI; kg/m Results: Among 456 participants with a breast cancer diagnosis (stage I-IIIC, mean age 55.9 years, 23.5 months post first-treatment, 86% white), 43.9% have obesity (BMI ≥ 30 kg/m Discussion: Overweight/obesity and CRF are highly prevalent among breast cancer survivors. Survivors with obesity experience worse CRF compared to those with normal weight. Survivors with co-occurring overweight/obesity and severe CRF experience worse cardiorespiratory function, and this persists post-diagnosis. Given the long-term detrimental impact of these conditions on QOL and survival, these findings underscore the need for targeted interventions.
Indexed as
Breast cancercancer-related fatigueobesitysurvivorship
Identifiers
PMID42163939
PMCPMC13186251
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390